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ABSTRACT 17 
The present study aimed to investigate the inter- and intraday repeatability of reactive hyperemia 18 
index (RHI) measured by Endo-PAT in healthy volunteers.  19 
Interday RHI repeatability was tested in two consecutive days in a group of thirty-one male 20 
subjects. Intraday repeatability was investigated at baseline and after 2 and 4 h in a group of sixteen 21 
volunteers. Data were evaluated by analysis of variance. Bland–Altman plot, coefficient of variation 22 
(CV), coefficient of repeatability (CR) and intraclass correlation coefficient (ICC) were measured.  23 
While interday RHI repeatability was found to be reliable (CV: 6.0%; CR: 0.51; ICC: 0.77), 24 
multiple evaluations within the same day significantly (p<0.001) affected RHI (repeatability of the 25 
measurement - CV: 18.8%; CR: 1.26; ICC: 0.48). In particular, a significant increase in RHI 26 
occurred at 4 h compared to 2 h (+16.8%; p<0.05) and to baseline (+30.1%; p<0.05).   27 
In conclusion, RHI showed good interday but poor intraday repeatability. Multiple evaluations 28 
increased RHI especially in subjects with endothelial dysfunction who improved or reversed their 29 
impairment. These results show the potential limitations of multiple Endo-PAT measurements 30 
within the same day and the importance of standardizing the protocols before RHI evaluations. 31 
 32 
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Abbreviations:  37 
AI, augmentation index; AI@75, augmentation index normalized for heart rate of 75 bpm; 38 
ANOVA, Analysis of variance; CR, coefficient of repeatability; CV, coefficient of variation; DBP, 39 
diastolic blood pressure; F-RHI; Framingham reactive hyperemia index; HR, heart rate; ICC, 40 
intraclass correlation coefficient; LSD, Least Significant Difference; PAT, peripheral arterial tone; 41 
RHI, reactive hyperemia index; SD, standard deviation; SEM, standard error of mean SBP; systolic 42 
blood pressure.  43 
44 
4 
 
INTRODUCTION 45 
Endo-PAT is a novel non-invasive plethysmographic system developed to measure 46 
peripheral arterial function at the level of the fingertips through an index of reactive hyperemia 47 
(RHI). This index is a ratio of the post-to-pre occlusion PAT amplitude of the tested arm, divided 48 
by the post-to-pre occlusion PAT amplitude of the control arm [1, 2]. Simultaneously with 49 
endothelial function, Endo-PAT can also measure the peripheral augmentation index (AIx), which 50 
is an established marker of arterial wave reflection [3]. Thus, PAT technology is particularly 51 
interesting for the application in clinical research studies, since the measurement of peripheral 52 
arterial function and arterial stiffness requires separate equipments. In addition, Endo-PAT has the 53 
advantage of providing reliable and reproducible results; it is operator-independent and it records 54 
systemic changes on the contra-lateral arm, allowing for an internal control system [4, 5]. Several 55 
studies have found a significant correlation between peripheral arterial tonometry and flow-56 
mediated dilation [6, 7], which represents the most popular clinical method to assess endothelial 57 
function by means of brachial artery ultrasound scanning [6, 7].   58 
Endothelial nutrition is a new and innovative concept that involves the study of the role of 59 
dietary compounds on endothelial function. Preventing the endothelium from becoming 60 
dysfunctional by means of nutrients or extra-nutrients that modulate vascular tone and maintain 61 
homeostasis of the endothelium, can be of great importance to human health. Endo-PAT has been 62 
used to evaluate the effect on arterial function of both short- and long-term exposure to foods and 63 
bioactive compounds, however the results are still conflicting [8-14]. This discordance may depend 64 
on subject characteristics such as age, sex, dietary and life-style habits and physical activity, but 65 
also on the experimental protocol used. A report of the International Brachial Artery Reactivity 66 
Task Force suggested that multiple measurements performed within the day can affect vascular 67 
function due to the stimulation of endothelial dependent mechanisms [6]. Multiple evaluations 68 
could affect endothelial function and arterial stiffness measurements, which would have significant 69 
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implications for clinical practice and for trials involving PAT measurements. This information is 70 
crucial since the effects of foods and/or bioactives in the modulation of vascular function could be 71 
of lower magnitude when compared to drugs, so that the overall impact on endothelial function may 72 
be masked or overestimated following multiple measurements. Therefore, the aim of the present 73 
study was to evaluate the intra- and interday repeatability of arterial function measurements by 74 
Endo-PAT in a group of healthy male volunteers. The evaluation of intra- and interday 75 
measurement repeatability is pivotal for the interpretation of RHI values and their variations over 76 
time, as well as for designing clinical trials and determining the appropriate sample size.  77 
 78 
Materials and Methods 79 
Subjects recruitment 80 
A homogeneous group of 47 healthy, male volunteers was recruited from the student population of 81 
the University of Milan. Subjects were selected according to the following criteria: 20-30 years of 82 
age, not overweight, non-smokers, moderate physical activity (25-30 min per day of brisk walk or 83 
jog) and moderate alcohol consumption (up to 10-14 drinks, expressed as red wine or beer, per 84 
week). Subjects were selected based on an interview to evaluate their dietary habits and the use of a 85 
food frequency questionnaire. Subjects declared no history of cardiovascular, coronary, diabetes, 86 
hepatic, renal, or gastrointestinal diseases, dyslipidemia, anemia, chronic asthma, allergy, traumas 87 
of the arms or hand, fingers, atopic dermatitis, thyroid disturbance, depression, anxiety, palpitations 88 
and chronic backache. Moreover, subjects did not make use of supplements, drugs or medications 89 
for at least one month before the beginning of the study.  90 
 91 
Experimental design 92 
The study was performed in accordance with the ethical standards established in the 2003 93 
Declaration of Helsinki. All participants signed a written informed consent.  94 
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Subjects abstained from eating bioactive-rich foods for two days before the experimentation. 95 
Specific attention was devoted to foods with potential vasoactive properties such as chocolate, soft 96 
fruits (i.e. blueberries, strawberries), red or blue fruits, red wine, and green tea. Volunteers were 97 
asked to limit coffee intake to three espresso shots per day, as well as caffeine-rich beverages (e.g. 98 
energy drinks), to standardize their intake and reduce a factor affecting vascular function. The day 99 
before the experiment and during the trial, breakfast, lunch and dinner were standardized. Breakfast 100 
consisted of milk and biscuits, while lunch was composed of two sandwiches (one with cooked ham 101 
and cheese and one with raw ham). For dinner, subjects could eat pasta or rice with butter and 102 
cheese, a steak with potatoes, two slices of white bread and no more than one espresso coffee. 103 
Dinner was eaten by 9.00 pm. No alcoholic beverages or soft drinks were permitted. Overall, the 104 
meals were standardized in order to provide adequate energy/macronutrients intake, limiting 105 
bioactives and taking into account Italian dietary habits. Moreover, all participants were asked to 106 
refrain from physical activity from the day before the experiments.  107 
Interday repeatability of RHI was tested in 31 subjects at the same time of the day in two 108 
consecutive days. The day of the experiment, overnight-fasted subjects came to the laboratory of 109 
the University at 7.00 a.m. Intraday repeatability of RHI was tested in 16 subjects. The 110 
measurements were performed at 7.00 a.m. (time 0 h) after an overnight fast and at 2 and 4 h from 111 
the consumption of a standard light breakfast composed of milk and biscuits (about 200 kcal). In 112 
this protocol breakfast was added since a long fasting period could cause a stress condition in the 113 
volunteers.  114 
  115 
Evaluation of peripheral arterial function 116 
Endothelial-dependent vasodilation in the small finger arteries was assessed by Endo-PAT2000 117 
(Itamar Medical Ltd., Caesarea, Israel). The Endo-PAT equipment consists of two finger-mounted 118 
probes, which includes a system of inflatable latex air-cushions within a rigid external case; 119 
pulsatile volume changes of the fingertip are sensed by a pressure transducer, located at the end of 120 
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each probe, and transferred to a personal computer where the signal is band pass-filtered (0.3 to 30 121 
Hz), amplified, displayed, and stored. For the evaluation, subjects were in the supine position with 122 
both hands on the same level in a comfortable, thermo-neutral environment. Tests were performed 123 
in a dark, noise-and climate-controlled (22-24°C) room. Arterial systolic and diastolic blood 124 
pressure and heart rate frequency were measured before starting the test. A blood pressure cuff was 125 
placed on one upper arm (study arm), while the contralateral arm served as a control (control arm). 126 
After a 10-min equilibration period, the blood pressure cuff on the study arm was inflated to 60 127 
mmHg above systolic pressure for 5 min. The cuff was then deflated to induce reactive hyperemia 128 
(RH) while the signals from both PAT channels (Probe 1 and Probe 2) were recorded by a 129 
computer. The technique provides values for the calculation of RHI and Framingham (F) RHI, 130 
which give an indication of the endothelial vasodilator function [4, 15]. FRHI is an alternative 131 
method of calculating RHI, developed within the Framingham Heart Study. FRHI is automatically 132 
provided by the instrument and calculated by taking into account a different post-occlusion 133 
hyperemia period (90 to 120 s) without baseline correction factor. Evidence from the Framingham 134 
Heart Study suggested a strong correlation between FRHI and cardiovascular risk [15]. Low RHI 135 
and FRHI scores indicate endothelial dysfunction. A RHI value of 1.67 provides a sensitivity of 136 
82% and a specificity of 77% for diagnosing endothelial dysfunction [16]. The Endo-PAT device 137 
also generates the digital augmentation index (AI), a measure of pulse wave reflection and a 138 
surrogate marker for arterial stiffness. Augmentation index derived from digital pulse volume 139 
waveforms and strongly correlated to aortic AI. Peripheral AI is calculated from the shape of the 140 
pulse wave recorded by the probes during baseline [17-18]. Because digital AI is influenced in an 141 
inverse and linear manner by heart rate, the AI was automatically normalized by considering a heart 142 
rate of 75 bpm (AI@75).   143 
 144 
 145 
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Statistical analysis 146 
Thirty-one subjects were enrolled for the inter-day RHI repeatability assuming a power of 80%, alfa 147 
= 0.05, K measurements = 2 and width of the 95% confidence interval for sw = 0.25. As regards the 148 
intraday RHI repeatability, sixteen subjects were recruited assuming a power of 80%, alfa = 0.05, K 149 
measurements = 3 and width of the 95% confidence interval for sw = 0.25. Within subjects standard 150 
deviation sw, of repeated measurements was used to estimate sample size. 151 
One way repeated-measures analysis of variance (ANOVA) was used to compare the data obtained 152 
for intraday repeatability; post-hoc analysis of differences between paired data was assessed, when 153 
appropriate, by the Least Significant Difference (LSD). Differences between interday 154 
measurements were analyzed by paired Student t-test. 155 
The agreement between paired (intraday and interday) measurements was assessed with the Bland-156 
Altman method in which the differences between two repeated measurements were plotted with 157 
their mean [19]. In the plot, horizontal lines were drawn at the mean difference and the 95% limits 158 
of agreement, defined as the mean difference ±1.96 times the standard deviation of the differences.  159 
Coefficient of repeatability (CR) was calculated, as suggested by Bland and Altman, multiplying 160 
the standard deviation of the differences between the two measurements for 1.96 [19]. This value 161 
provides an interval, within which 95% of test-retest measurement differences lie. 162 
Coefficient of variation (CV) was reported and expressed as a percentage. CV derives from the 163 
formula (average of individual standard deviations / average of individual means) x 100; a lower 164 
CV was associated with higher repeatability.  165 
Test-retest reliability was assessed by intraclass correlation coefficient (ICC). ICC, that measures 166 
the extent of absolute agreement, is defined as the ratio of the between-subjects variance to the sum 167 
of the pooled within-subject variance and the between-subjects variance and it derives from two-168 
way random effects ANOVA [20]. The ICCs range from 0 to 1 and are classified as follows: ICC 169 
<0.75 poor agreement, 0.75-0.90 moderate agreement, and >0.90 high agreement [21].  170 
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A two tailed P < 0.05 was considered statistically significant. Statistical analysis was performed 171 
using SPSS for Windows, release 17.0 (SPSS, Chicago, IL). Data are presented as mean values ± 172 
standard error of the mean (SEM). 173 
 174 
RESULTS 175 
Characteristics of the subjects 176 
The anthropometric and clinical characteristics of the forty-seven subjects enrolled for the inter- and 177 
intraday reproducibility study are reported in Table 1. Blood pressure and BMI were in the normal 178 
range. Nineteen out of 47 subjects showed endothelial dysfunction (RHI <1.67).  179 
 180 
Interday repeatability 181 
The interday repeatability of RHI, FRHI and AI@75 measured at day 1 and day 2 are reported in 182 
Figure 1 (A-C). The Bland–Altman graphs documenting the degree of concordance between the 183 
pairs of measurements obtained on separate days for RHI, FRHI and AI@75 are shown in Figure 2 184 
(A-C). No significant difference between days has been observed for all the parameters under 185 
study. CV, CR and ICC of RHI were 5.8%, 0.47 and 0.79, respectively. FRHI showed a CV of 186 
21.1%, a CR of 0.39 and ICC of 0.79. AI@75 showed a good level of reliability (ICC: 0.88) 187 
between days, but poor repeatability (CR: 1.74). In particular, Bland–Altman graph (Figure 2C) 188 
displays a clear upward slope due to a high intra-individual variability of AI@75 between days.    189 
 190 
Intraday repeatability 191 
The intraday repeatability of RHI, FRHI and AI@75 are reported in Figure 3 (A-C). Multiple 192 
evaluations within the day significantly affected RHI (p=0.001), FRHI (p<0.001) and the 193 
repeatability of the measurements. RHI significantly increased at 4 h compared to baseline 194 
(+30.1%, p<0.05) and 2 h (+16.8%, p<0.05), while no significant effect was observed at 2 h with 195 
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respect to baseline (+11.2%; p>0.05). The improvement of arterial function at 4 h was particularly 196 
evident in the group of subjects with endothelial dysfunction (RHI from 1.40 ± 0.08 to 2.05 ± 0.14; 197 
p<0.001; n =8) compared to the group of subjects with normal endothelial function (RHI from 2.40 198 
± 0.57 to 2.63 ± 0.53 RHI; p= 0.063; n=8). On the whole, RHI repeatability was high until 2 h (CV: 199 
7.71%; CR: 0.56; ICC: 0.91) but low after 4 h (CV: 18.8%; CR: 1.26; ICC: 0.53).  200 
FRHI significantly increased after 2 h (+233%; p<0.01) and 4 h (+337%; p<0.001) with respect to 201 
baseline, and it was also high at 4 h (+76.5%; p<0.001) compared to 2 h. These results were also 202 
confirmed by the low repeatability after 2 h (CV: 34.4%; CR: 0.52; ICC: 0.83) and 4 h (CV: 58.8%; 203 
CR: 1.08; ICC: 0.42) compared to baseline.  204 
Multiple measurements significantly affected arterial stiffness (AI@75; p<0.01). In particular, a 205 
significant reduction was observed after 2 h compared to baseline (-25.3%; p<0.01) and 4 h (-206 
17.5%; p<0.01), while no significant difference was observed between baseline and 4 h. The test-207 
retest repeatability was low both at 2 h (CV:13%; CR:13.0; ICC: 0.60) and 4 h (CV:15%; CR:11.8; 208 
ICC:0.73).  209 
The Bland–Altman plots of the RHI, FRHI and AI@75 measurements (time interval: 0 h vs 2 h, and 210 
0 h vs 4 h) are shown in Figure 4 A-C. On the whole, the graph plots indicate a clear upward slope 211 
and a high intra-individual variability between measures for each variable at all time points.  212 
To exclude the contribution of breakfast in the modulation of RHI repeatability, a group of 8 213 
volunteers repeated intraday measurement in a fasting condition (Figure 5 A-C). The results 214 
showed that multiple evaluations within the day significantly affected RHI also in the fasting 215 
condition. In particular, RHI significantly increased at 4 h compared to baseline (from 1.84±0.34 to 216 
2.27±0.44 RHI; +23.4%; p<0.01) while no significant increase occurred after 2 h with respect to 217 
baseline (from 1.84±0.34 to 2.08±0.38 RHI; p>0.05). RHI repeatability was high until 2 h (CV: 218 
8.71%; CR: 0.62; ICC: 0.71) but low after 4 h (CV: 19.7%; CR: 1.33; ICC: 0.11).  219 
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FRHI significantly increased after 4 h (from 0.49±0.16 to 0.79±0.14 FRHI +527%; p<0.01) 220 
compared to baseline, while no difference was observed at 2 h (p=0.06), and between 2 and 4 h 221 
(p=0.34). However, a low repeatability after 2 h (CV: 24.1%; CR: 0.63; ICC: 0.78) and 4 h (CV: 222 
36.6%; CR: 0.91; ICC: 0.54) was observed compared to baseline.  223 
Regarding arterial stiffness (AI@75), no significant difference occurred between test and retest 224 
without breakfast at 2 h and 4 h compared to baseline (p=0.52). The test-retest repeatability was low 225 
both at 2 h (CR:26.3; ICC: 0.91) and 4 h (CR:15.2; ICC:0.96).  226 
The Bland–Altman plots of the RHI, FRHI and AI@75 measurements (time interval: 0 h vs 2 h, and 227 
0 h vs 4 h) documented a high intra-individual variability between measures for each variable at all 228 
time points (data not shown). 229 
 230 
Discussion 231 
Together with other studies, we previously reported the feasibility of using the Endo-PAT technique 232 
to measure improvements of endothelial function following dietary interventions, lifestyle 233 
modifications or pharmacological treatments [8, 18, 22-26]. However, information about the 234 
performance of this tool in intervention trials is limited. For example, we recently documented that 235 
one portion of blueberry was able to counteract an impairment of endothelial function following 236 
acute cigarette smoking evaluated through RHI measurements performed in two separate occasions 237 
(i.e. day 1: baseline; day 2: treatment) [26]. This protocol was selected since we observed an 238 
improvement in endothelial function following multiple RHI measurements in the same day. Here, 239 
we reported the inter- and intra-day repeatability of Endo-PAT in a group of volunteers with 240 
characteristics (e.g. lifestyles, dietary habits) comparable with those of the subjects involved in the 241 
previous trial. The results obtained in the present study suggest that the measurements of peripheral 242 
arterial function (RHI and FRHI), but not arterial stiffness, are reproducible when assessed in two 243 
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consecutive days. On the contrary, it was found that multiple measurements within the same day 244 
increased RHI and FRHI and temporarily reduced AI@75.  245 
In the present study, we observed a small CV for RHI (about 6%) and a good ICC for RHI, FRHI 246 
and AI@75 (0.77, 0.79 and 0.88, respectively). These results are in accordance with data reported 247 
by others authors [7, 27-29]. Onkelinx et al. showed no difference in RHI index between days and a 248 
good coefficient of variation (CV: 11%) and intraclass correlation coefficient (ICC: 0.73) of the 249 
measurements in a group of male patients with coronary artery disease [7]. Sauder et al. showed a 250 
robust RHI repeatability (ICC: 0.74) between days in a group of subjects with metabolic syndrome 251 
[29]. Liu et al. reported no significant differences in the RHI values measured at the same time 252 
points on each of the 3 days tested in a group of healthy male volunteers [27]. However, the ICC for 253 
RHI measured at 2-hour intervals (from 8.00 am to 8.00 pm) among the 3 days was very low (ICC: 254 
0.03-0.46). In addition, the authors reported that the mean intra-individual coefficient of variation 255 
for arterial stiffness was rather variable (37%) [27]. On the contrary, McCrea et al. reported a good 256 
ICC for RHI and arterial stiffness (0.74 and 0.83, respectively) evaluated for two measurements 257 
performed within a week in a group of healthy subjects [28]. Selamet et al. investigated RHI 258 
repeatability in a large cohort of healthy adolescents and documented an excellent repeatability with 259 
an ICC of 0.78 when the measurements were performed in two separate occasions [30]. Degnan et 260 
al. showed a low ICC for RHI but excellent for arterial stiffness (0.43 and 0.78, respectively) when 261 
the tests were performed in three separate occasions in a group of healthy female subjects [31]. 262 
Conversely, in our study a low reliability of arterial stiffness was found suggesting that the 263 
measurements between days were not reproducible. This result may be attributed to the small 264 
arteries of the fingertips that are more sensitive than brachial arteries and are more susceptible to 265 
variations in sympathetic nervous system activity.  266 
Regarding the intraday repeatability, we previously reported that multiple measurements within the 267 
day can affect arterial function, thus a minimum time interval (at least 2 hours from our 268 
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observations) between test and retest should be recommended also in accordance to the data 269 
reported in the literature [6;27]. In addition, it is widely recognized that RHI is influenced by 270 
temperature, sympathetic nervous system activity and humoral factors [32]. In the present 271 
experiment, we tried to limit the possible confounding factors by standardizing the dietary habits 272 
and lifestyle of participants, by repeating the measurements at intervals of 2 hours, by maintaining a 273 
constant temperature in the room, and by providing a comfortable environment for all patients. We 274 
documented that multiple measurements within the same day caused a significant increase at 4 h for 275 
RHI and at 2 and 4 h for FRHI compared to baseline. In particular, the improvement of arterial 276 
function at 4 h was particularly high in the group of subjects with initial endothelial dysfunction 277 
that was reversed following the multiple measurements.  278 
The effect of multiple measurements on RHI values was poorly investigated in the literature and the 279 
results available are quite controversial. Onkelinx et al. reported a significant increase in RHI 280 
values when the tests were performed at intervals of 30 minutes [7]. Similar results were also 281 
observed by Liu and coworkers that reported a significant increase in RHI when measurements 282 
were carried out at 0.5 h intervals for 6 h, hypothesizing a crossover effect [27]. However, when the 283 
authors performed the measurements at intervals of 1 and 2 h, the values were comparable and no 284 
significant changes occurred compared to baseline [27]. Forchammer et al. showed a good intra-day 285 
RHI reproducibility in a group of healthy subjects when endothelial function was assessed in four 286 
different occasions (in the morning, before and after lunch, in the afternoon) within the same day 287 
[33].  288 
In the present study, subjects consumed a light breakfast early in the morning before the test in 289 
order to avoid the potential effect of long term fasting on vascular function. However, it is 290 
recognized that consumption of a meal can affect RHI; this can also depend on subjective metabolic 291 
features [27-28]. In literature, we could not find data comparing the effect of overnight fasting 292 
versus breakfast intake on RHI intraday repeatability. In order to exclude the contribution of 293 
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breakfast to the results obtained, we asked to a group of volunteers to repeat intraday measurement 294 
in a fasting condition. Only 8 out of 16 subjects previously enrolled joined the study and completed 295 
the test. Overall, data obtained on the overnight-fasted group of participants were in line with those 296 
found following the light breakfast consumption. The improvement observed could be attributed to 297 
several variables such as sympathetic nervous system activity, diurnal rythms, ischemic 298 
preconditioning mechanisms, or production of endothelial-dependent (e.g. endothelium-derived 299 
relaxing factors) or endothelial-independent (e.g. leptin, glucagon-like peptide 1) factors able to 300 
induce vasodilation [34-35]. In this regard, several studies showed that insulin induces changes in 301 
microvascular vasomotion, promotes capillary recruitment and NO synthesis [36-37]. The binding 302 
of insulin to its receptor on endothelium could lead to the activation of eNOS pathway and 303 
vasodilation [38-39]. These observations can be useful to explain the results obtained in our study 304 
after consuming breakfast. On the other hand, low blood-sugar levels in the fasting state bring to a 305 
decrease in insulin secretion and a rise in glucagon secretion. Glucagon stimulates glycogen 306 
breakdown and inhibits glycogen synthesis by triggering the cyclic adenosine monophosphate 307 
(AMP) cascade. An increase in endothelial cyclic AMP levels showed to amplify agonist-induced 308 
formation of endothelium-derived relaxing factor that plays a pivotal role in the vasodilation [40]. 309 
Moreover, we cannot exclude that the improvement of endothelial function could be somehow 310 
related to a shift in the energy fuel used during fasting condition, even if all these hypotheses 311 
remain to be ascertained.  312 
Digital AI reflects changes in vessel diameter, blood pressure and heart rate [41]. We 313 
considered the value of digital AI standardized for the heart rate provided by the Endo-PAT system, 314 
documenting a significant decrease in AI@75 at 2 h, but not at 4 h, compared to baseline only after 315 
the consumption of breakfast. Albeit temporary, this improvement was not dependent on heart rate 316 
as no significant change occurred for this variable. Since insulin have been reported to play a 317 
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beneficial effect on arterial stiffness both in healthy and diabetic subjects [37,42], its involvement 318 
cannot be excluded.  319 
Strengths and limitations of the study 320 
In the present study, we tried to eliminate as many confounding factors as possible affecting the 321 
endothelial function and its variability; for example we selected a homogenous population for 322 
dietary, smoking (non-smokers) and physical activity habits. All the subjects were healthy and did 323 
not take any supplement or medication. Moreover, we standardized the meals the day before and the 324 
breakfast the day of the experiment in order to limit postprandial effects. In addition, the testing 325 
procedure was standardized for the posture of the subjects, the probe placement, the time of the day, 326 
the room temperature and the resting period to eliminate, or at least to limit, the sympathetic 327 
stimulation prior to testing. The use of a light breakfast could have had an impact on results 328 
obtained; however, the study performed on starved subjects, as control confirmed results on the 329 
time-dependent RHI intraday variability.  Owing to the many variables that can affect the reliability 330 
of measurements, the use of well-described, standardized and controlled protocols is highly 331 
recommended with a particular focus on occlusion times and metabolic state of the subjects, in 332 
order to avoid crossover effects and limit as much as possible the confounding factors. 333 
Conclusions 334 
In conclusion, we documented a good interday repeatability for RHI measurements. 335 
Conversely, intraday repeatability was influenced by the number of measurements and generally 336 
accepted when performed up to 2 h. Subjects with endothelial dysfunction seemed to be more prone 337 
to modifications following multiple measurements causing a reversal of vascular impairment. 338 
Further studies are needed in order to elucidate the effects of multiple measurements on RHI, FRHI 339 
and AI@75, especially before performing clinical or dietary intervention studies. A specific 340 
attention should be devoted to subjects with endothelial dysfunction whose RHI improvement 341 
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merits further investigation and to the role of insulin and glucagon in the modulation of vascular 342 
function. 343 
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Figure 1: Interday repeatability of RHI, FRHI and AI@75 measured in two consecutive days 483 
by Endo-PAT2000 484 
 485 
Figure legend 486 
Subjects involved: n=31 487 
RHI, reactive hyperemia index; FRHI, Framingham reactive hyperemia index; AI@75, arterial 488 
stiffness standardized for heart rate. 489 
Data are expressed as mean ± standard error of the mean. 490 
 491 
Figure 2: Bland-Altman plot: the difference between the two measurements for RHI (2A), 492 
FRHI (2B) and AI@75 (2C) is plotted. The continuous line represents the mean of differences 493 
and the broken lines the 95% limits of agreement (± 1.96 SD of the differences) 494 
 495 
Figure legend 496 
Subjects involved: n=31 497 
RHI, reactive hyperemia index; FRHI, Framingham reactive hyperemia index; AI@75, arterial 498 
stiffness standardized for heart rate. 499 
 500 
Figure 3: Intraday repeatability of RHI, FRHI and AI@75 measured at intervals of 2 hours 501 
from a light breakfast by Endo-PAT2000 502 
 503 
Figure legend 504 
Subjects involved: n=16 505 
RHI, reactive hyperemia index; FRHI, Framingham reactive hyperemia index; AI@75, arterial 506 
stiffness standardized for heart rate. 507 
24 
 
Data are expressed as mean ± standard error of the mean. 508 
a,b,c Data with different letters are significantly different (p<0.05) 509 
 510 
Figure 4: Bland-Altman plot: the difference between two measurements after a light 511 
breakfast (time 0 h vs time 2 h, and time 0 h vs time 4 h) for RHI (4A), FRHI (4B) and AI@75 512 
(4C) is plotted. The continuous line represents the mean of differences and the broken lines 513 
the 95% limits of agreement (± 1.96 SD of the differences) 514 
 515 
Figure legend 516 
Subjects involved: n=16 517 
RHI, reactive hyperemia index; FRHI, Framingham reactive hyperemia index; AI@75, arterial 518 
stiffness standardized for heart rate. 519 
 520 
Figure 5: Intraday repeatability of RHI, FRHI and AI@75 measured at intervals of 2 hours in 521 
fasting conditions by Endo-PAT2000 522 
 523 
Figure legend 524 
Subjects involved: n=8 525 
RHI, reactive hyperemia index; FRHI, Framingham reactive hyperemia index; AI@75, arterial 526 
stiffness standardized for heart rate. 527 
 528 
 529 
